- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
弱势下跌过程中，可逢高卖出，暂不考虑买进。
- 中期趋势：
回落整理中且下跌趋势有所减缓。
- 长期趋势：
已有32家主力机构披露2025-06-30报告期持股数据，持仓量总计5117.67万股，占流通A股23.99%
- 波段诊断：
-
技术面诊股
诊断结果：5.8技术面打败了33%的股票
技术面评分前10的股票
近期的平均成本为21.60元。多头行情中，目前处于回落整理阶段且下跌趋势有所减缓。
平均成本
近期的平均成本为21.60元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"21.60","date":1760260608,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势明显跑输大盘，接近行业平均水平。
[{"date":"2025.10.13","stock":"-1.22","trade":"-0.84","ind":"-0.19"},{"date":"2025.10.10","stock":"-0.14","trade":"-0.24","ind":"-0.94"},{"date":"2025.10.09","stock":"1.75","trade":"-0.39","ind":"1.32"},{"date":"2025.09.30","stock":"0.65","trade":"0.72","ind":"0.52"},{"date":"2025.09.29","stock":"0.05","trade":"-0.14","ind":"0.90"},{"date":"2025.09.26","stock":"-2.39","trade":"-1.67","ind":"-0.65"},{"date":"2025.09.25","stock":"-1.21","trade":"-0.91","ind":"-0.01"},{"date":"2025.09.24","stock":"2.14","trade":"1.94","ind":"0.83"},{"date":"2025.09.23","stock":"-3.31","trade":"-1.95","ind":"-0.18"},{"date":"2025.09.22","stock":"-0.22","trade":"-0.40","ind":"0.22"},{"date":"2025.09.19","stock":"-2.40","trade":"-1.50","ind":"-0.30"},{"date":"2025.09.18","stock":"-1.36","trade":"-0.61","ind":"-1.15"},{"date":"2025.09.17","stock":"-1.58","trade":"-0.67","ind":"0.37"},{"date":"2025.09.16","stock":"-0.66","trade":"-0.09","ind":"0.04"},{"date":"2025.09.15","stock":"-1.39","trade":"-0.14","ind":"-0.26"},{"date":"2025.09.12","stock":"-0.24","trade":"0.60","ind":"-0.12"},{"date":"2025.09.11","stock":"0.66","trade":"0.29","ind":"1.65"},{"date":"2025.09.10","stock":"-1.93","trade":"-0.63","ind":"0.13"},{"date":"2025.09.09","stock":"-3.30","trade":"-1.92","ind":"-0.51"},{"date":"2025.09.08","stock":"1.94","trade":"0.35","ind":"0.38"},{"date":"2025.09.05","stock":"3.11","trade":"1.70","ind":"1.24"}]
美诺华,上证指数,化学制药指数
压力支撑
该股压力位为21.30元，支撑位为20.60元。
[{"text":"\u538b\u529b\u4f4d","value":"21.30","date":1760284800,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"20.60","date":1760284800,"color":"0x0b52a1"}]
多空趋势
多头行情中，目前处于回落整理阶段且下跌趋势有所减缓。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：3.0资金面打败了19%的股票
主力控盘前10的股票
行业资金
化学制药行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：10月13日 20:39
| 机构今日流向(万元) | -481.57 | 机构5日流向(万元) | -3854.21 |
| 机构10日流向(万元) | -9725.60 | 机构20日流向(万元) | -27623.11 |
机构持仓
2025-06-30 与 2024-12-31 相比，主力机构持仓量减少543.97万股，其中基金净减仓3家，主力净减仓69家，请投资者中长期谨慎为宜。
截止2025-06-30，共32家主力机构（基金29家，QFII2家，一般法人1家），持仓量总计5117.67万股，占流通A股23.99%
其中，基金持仓与2024-12-31相比：
增仓：1家 ，增持 13.63万股
减仓：4家 ，减持 5.37万股
新出现在主力名单中：25家 ，持有530.23万股
从主力名单中消失：94家 ，原持有1082.46万股
其中，基金持仓与2024-12-31相比：
增仓：1家 ，增持 13.63万股
减仓：4家 ，减持 5.37万股
新出现在主力名单中：25家 ，持有530.23万股
从主力名单中消失：94家 ，原持有1082.46万股
消息面诊股
诊断结果：6.3消息面打败了95%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 美诺华：10月10日获融资买入2549.38万元
2025-10-11 - 美诺华：10月9日获融资买入2290.26万元
2025-10-10 - 美诺华：9月30日获融资买入1392.68万元
2025-10-01 - 美诺华：9月29日获融资买入1188.06万元
2025-09-30 - 美诺华心衰产品线添强援：沙库巴曲缬沙坦钠片获批，瞄
2025-09-29 - 美诺华与马来西亚Dubhelion签署战略合作协议
2025-09-29 - 美诺华双榜题名！研发筑基、创新领航撬动40亿增量市
2025-09-29 - 美诺华：9月26日获融资买入1207.47万元
2025-09-27 - 美诺华：9月25日获融资买入1538.56万元
2025-09-26 - MNC“扫货”海外减肥药资产触发连锁反应 国内企业
2025-09-25
消息列表
| 一般消息 | 募资投向 | 2025-09-19 | |
| 一般消息 | 高管变动 | 取消监事会 | 2025-09-11 |
| 一般消息 | 股东大会 | 临时股东大会 | 2025-08-27 |
| 一般消息 | 分红转增 | 不分配不转增 | 2025-08-27 |
| 一般消息 | 募资投向 | 公司购买资产 | 2025-08-27 |
| 重大利好 | 业绩预告 | 业绩大幅上升 | 2025-07-03 |
| 一般消息 | 重大事项 | 关联交易 | 2025-05-09 |
| 利好 | 分红转增 | 10派0.50元(含税) | 2025-04-18 |
| 一般消息 | 重大事项 | 关联交易 | 2025-04-02 |
| 重大利好 | 业绩预告 | 业绩大幅上升 | 2025-01-28 |
| 一般消息 | 重大事项 | 关联交易 | 2025-01-15 |
| 利空 | 重大事项 | 公司违规：处罚类型 | 2024-12-04 |
| 利空 | 重大事项 | 公司违规：处罚类型 | 2024-11-11 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 3条 | 2条 | 1条 |
| 利空 | 2条 | 0条 | 2条 |
行业面诊股
诊断结果：1.7行业面打败了19%的股票
化学制药行业最新资金流向
近10日来该行业走势不明显，明显跑输大盘。
行业走势
近10日来该行业走势不明显，明显跑输大盘。
[{"date":"2025.10.13","price":"-0.19","value":"-0.84"},{"date":"2025.10.10","price":"-0.94","value":"-0.24"},{"date":"2025.10.09","price":"1.32","value":"-0.39"},{"date":"2025.09.30","price":"0.52","value":"0.72"},{"date":"2025.09.29","price":"0.90","value":"-0.14"},{"date":"2025.09.26","price":"-0.65","value":"-1.67"},{"date":"2025.09.25","price":"-0.01","value":"-0.91"},{"date":"2025.09.24","price":"0.83","value":"1.94"},{"date":"2025.09.23","price":"-0.18","value":"-1.95"},{"date":"2025.09.22","price":"0.22","value":"-0.40"},{"date":"2025.09.19","price":"-0.30","value":"-1.50"},{"date":"2025.09.18","price":"-1.15","value":"-0.61"},{"date":"2025.09.17","price":"0.37","value":"-0.67"},{"date":"2025.09.16","price":"0.04","value":"-0.09"},{"date":"2025.09.15","price":"-0.26","value":"-0.14"},{"date":"2025.09.12","price":"-0.12","value":"0.60"},{"date":"2025.09.11","price":"1.65","value":"0.29"},{"date":"2025.09.10","price":"0.13","value":"-0.63"},{"date":"2025.09.09","price":"-0.51","value":"-1.92"},{"date":"2025.09.08","price":"0.38","value":"0.35"},{"date":"2025.09.05","price":"1.24","value":"1.70"}]
上证指数,化学制药行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 向日葵 | 73.72% | -13.03% | 5.2分 |
| 2 | 宏源药业 | 18.25% | 24.58% | 5.7分 |
| 3 | 康芝药业 | 7.12% | -0.14% | 5.8分 |
| 4 | 纳微科技 | 5.16% | 0.54% | 6.8分 |
| 5 | 华纳药厂 | 4.85% | 7.11% | 6.5分 |
| 6 | ST天圣 | 3.85% | -0.61% | 4.7分 |
| 8 | 河化股份 | 3.67% | 1.52% | 6.4分 |
| 10 | 恩华药业 | 3.07% | -4.47% | 4.8分 |
| 12 | 常山药业 | 1.83% | 10.49% | 6.1分 |
| 14 | 新和成 | 1.12% | 2.79% | 6.5分 |
| 16 | 国邦医药 | -0.55% | 5.11% | 6.3分 |
| 18 | 鲁抗医药 | -1.11% | 0.20% | 5.9分 |
| 20 | *ST苏吴 | -1.96% | -4.76% | 5.1分 |
| 22 | 海正药业 | -2.16% | 1.36% | 5.7分 |
| 24 | ST景峰 | -2.34% | -0.68% | 4.5分 |
| 26 | 海森药业 | -2.46% | 3.21% | 5.1分 |
| 28 | 共同药业 | -2.49% | 0.80% | 5.5分 |
| 30 | 海翔药业 | -3.03% | 1.94% | 5.0分 |
| 32 | 海欣股份 | -3.11% | 0.00% | 5.6分 |
| 34 | 华邦健康 | -3.40% | 2.25% | 5.8分 |
| 36 | 人福医药 | -3.74% | 0.09% | 5.7分 |
| 38 | 花园生物 | -3.98% | -2.03% | 5.1分 |
| 40 | 福安药业 | -4.18% | 1.63% | 5.4分 |
| 42 | 华北制药 | -4.21% | 2.07% | 6.1分 |
| 44 | 小方制药 | -4.30% | -0.63% | 5.2分 |
| 46 | 兴齐眼药 | -4.37% | 4.01% | 5.7分 |
| 48 | 丰原药业 | -4.59% | -0.77% | 5.4分 |
| 50 | 广济药业 | -4.70% | 0.64% | 5.8分 |
| 52 | 复星医药 | -4.80% | -1.78% | 5.3分 |
| 54 | 力生制药 | -5.13% | 3.44% | 6.1分 |
| 56 | 国药现代 | -5.16% | -0.09% | 5.7分 |
| 58 | 威尔药业 | -5.26% | 1.30% | 5.9分 |
| 60 | 信立泰 | -5.37% | -8.98% | 6.4分 |
| 62 | 浙江医药 | -5.44% | 1.26% | 5.9分 |
| 64 | 新天地 | -5.70% | 2.19% | 5.3分 |
| 66 | 易明医药 | -5.84% | -4.10% | 4.9分 |
| 68 | 西点药业 | -5.99% | 2.02% | 5.4分 |
| 70 | *ST三圣 | -6.35% | -1.08% | 4.0分 |
| 72 | ST诺泰 | -6.66% | -7.11% | 5.1分 |
| 74 | 京新药业 | -6.82% | -3.65% | 4.9分 |
| 76 | 百利天恒 | -6.89% | -3.11% | 5.4分 |
| 78 | 拓新药业 | -7.01% | 0.66% | 4.9分 |
| 80 | 赛托生物 | -7.28% | 0.27% | 5.0分 |
| 82 | 一品红 | -7.32% | 10.91% | 6.4分 |
| 84 | 复旦张江 | -7.52% | 0.78% | 5.5分 |
| 86 | 莱美药业 | -8.01% | -1.39% | 5.3分 |
| 88 | 神奇制药 | -8.11% | -4.23% | 5.5分 |
| 90 | 丽珠集团 | -8.27% | -0.18% | 5.8分 |
| 92 | 同和药业 | -8.30% | 0.35% | 5.6分 |
| 94 | 东诚药业 | -8.45% | 0.74% | 6.0分 |
| 96 | 润都股份 | -8.51% | 1.27% | 5.2分 |
| 98 | 海南海药 | -8.80% | -0.19% | 5.4分 |
| 100 | 健康元 | -9.12% | 0.16% | 5.5分 |
| 102 | 奥翔药业 | -9.57% | -0.40% | 5.6分 |
| 104 | 昂利康 | -9.89% | 1.58% | 6.1分 |
| 106 | 灵康药业 | -10.17% | -4.09% | 5.4分 |
| 108 | 尔康制药 | -10.29% | -2.58% | 5.0分 |
| 110 | 千红制药 | -11.08% | 0.00% | 5.0分 |
| 112 | 百济神州 | -11.15% | -5.86% | 5.0分 |
| 114 | 亚太药业 | -11.54% | -3.08% | 5.3分 |
| 116 | 多瑞医药 | -11.76% | -4.48% | 5.2分 |
| 118 | 能特科技 | -12.09% | 1.89% | 5.7分 |
| 120 | - | -12.14% | 2.94% | 分 |
| 122 | 立方制药 | -12.28% | 5.22% | 6.5分 |
| 124 | 诚意药业 | -12.54% | -2.40% | 6.0分 |
| 126 | 海创药业 | -13.35% | -4.32% | 5.5分 |
| 128 | 海思科 | -13.55% | -6.63% | 5.6分 |
| 130 | 首药控股 | -13.88% | -11.94% | 4.6分 |
| 132 | 汇宇制药 | -14.04% | -5.83% | 5.0分 |
| 134 | 上海谊众 | -15.45% | -3.16% | 5.5分 |
| 136 | 舒泰神 | -15.76% | 0.86% | 5.8分 |
| 138 | 翰宇药业 | -16.04% | -0.14% | 5.7分 |
| 140 | - | -16.15% | -2.63% | 分 |
| 142 | - | -16.57% | -0.59% | 分 |
| 144 | 吉贝尔 | -16.94% | -6.21% | 5.3分 |
| 146 | 海辰药业 | -17.57% | 9.09% | 5.3分 |
| 148 | 北陆药业 | -17.86% | -2.30% | 5.1分 |
| 150 | 新诺威 | -24.46% | -9.58% | 4.9分 |
| 152 | ST复华 | -26.10% | -11.89% | 4.5分 |
| 154 | 益方生物 | -32.54% | -10.62% | 4.9分 |
| 156 | 博瑞医药 | -42.61% | -4.10% | 5.0分 |
行业评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 暂无相关评级 |
更多>>行业资讯
- 2012-02-17青岛：加快向“世界强港”转型新增万吨级泊位24个
- 2012-02-17江苏港口发展“四稳四进”
- 2012-02-17今年河北省重点打造综合性港口群
- 2012-02-16招商轮船：非公开发行A股股票申请获得中国证券监督管理委员会核准
- 2012-02-16泉州市今年将冲刺“亿吨大港”
- 2012-02-16大连市集装箱运输生产“逆市飘红”
- 2012-02-16江苏港口发展“四稳四进”
- 2012-02-16连云港港：绿色生态大港正向我们走来
- 2012-02-15靖江今年港口建设预投28亿元 完成港口货物吞吐量8000万吨
- 2012-02-15舟山“大港口”建设撬动群岛新区大盘
基本面诊股
[ 截止日期：2025-06-30 ]公司经营
盈利能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 84/218 ， 109/218。
[{"date":"2025-06-30","value":"2.21","vol":"1.40"},{"date":"2025-03-31","value":"0.96","vol":"-0.17"},{"date":"2024-12-31","value":"3.12","vol":"19.77"},{"date":"2024-09-30","value":"2.96","vol":"4.61"},{"date":"2024-06-30","value":"0.90","vol":"3.55"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
2.21 | 0.96 | 3.12 | 2.96 | 0.90 |
| 行业(%) | 1.40 | -0.17 | 19.77 | 4.61 | 3.55 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"32.45","vol":"49.76"},{"date":"2025-03-31","value":"31.42","vol":"49.23"},{"date":"2024-12-31","value":"32.61","vol":"51.11"},{"date":"2024-09-30","value":"31.88","vol":"50.51"},{"date":"2024-06-30","value":"29.51","vol":"50.85"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
32.45 | 31.42 | 32.61 | 31.88 | 29.51 |
| 行业(%) | 49.76 | 49.23 | 51.11 | 50.51 | 50.85 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 32/218 ， 12/218。
[{"date":"2025-06-30","value":"11.42","vol":"79.06"},{"date":"2025-03-31","value":"5.22","vol":"-0.84"},{"date":"2024-12-31","value":"12.85","vol":"17.88"},{"date":"2024-09-30","value":"2.21","vol":"45.69"},{"date":"2024-06-30","value":"4.40","vol":"710.38"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
11.42 | 5.22 | 12.85 | 2.21 | 4.40 |
| 行业(%) | 79.06 | -0.84 | 17.88 | 45.69 | 710.38 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"158.97","vol":"56.66"},{"date":"2025-03-31","value":"51.12","vol":"-21.21"},{"date":"2024-12-31","value":"476.64","vol":"-21.14"},{"date":"2024-09-30","value":"15.97","vol":"-32.33"},{"date":"2024-06-30","value":"-38.61","vol":"8.14"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
158.97 | 51.12 | 476.64 | 15.97 | -38.61 |
| 行业(%) | 56.66 | -21.21 | -21.14 | -32.33 | 8.14 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 96/218 ， 123/218。
[{"date":"2025-06-30","value":"0.15","vol":"0.21"},{"date":"2025-03-31","value":"0.06","vol":"0.10"},{"date":"2024-12-31","value":"0.30","vol":"0.43"},{"date":"2024-09-30","value":"0.21","vol":"0.33"},{"date":"2024-06-30","value":"0.14","vol":"0.23"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.15 | 0.06 | 0.30 | 0.21 | 0.14 |
| 行业(次) | 0.21 | 0.10 | 0.43 | 0.33 | 0.23 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"0.54","vol":"1.32"},{"date":"2025-03-31","value":"0.23","vol":"0.67"},{"date":"2024-12-31","value":"1.33","vol":"3.24"},{"date":"2024-09-30","value":"0.92","vol":"2.18"},{"date":"2024-06-30","value":"0.65","vol":"1.51"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
0.54 | 0.23 | 1.33 | 0.92 | 0.65 |
| 行业(次) | 1.32 | 0.67 | 3.24 | 2.18 | 1.51 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 108/218 ， 33/218。
[{"date":"2025-06-30","value":"4.63","vol":"2.81"},{"date":"2025-03-31","value":"-9.22","vol":"-28.76"},{"date":"2024-12-31","value":"6.03","vol":"-371.46"},{"date":"2024-09-30","value":"34.13","vol":"-9.87"},{"date":"2024-06-30","value":"2.88","vol":"-253.98"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 4.63 | -9.22 | 6.03 | 34.13 | 2.88 |
| 行业 | 2.81 | -28.76 | -371.46 | -9.87 | -253.98 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"0.45","vol":"1.73"},{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"1.30","vol":"1.99"},{"date":"2024-09-30","value":"","vol":"0.00"},{"date":"2024-06-30","value":"1.23","vol":"2.19"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | 0.45 | - | 1.30 | - | 1.23 |
| 行业 | 1.73 | 0.00 | 1.99 | 0.00 | 2.19 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 50/218 ， 44/218。
[{"date":"2025-06-30","value":"1.27","vol":"3.66"},{"date":"2025-03-31","value":"1.21","vol":"3.59"},{"date":"2024-12-31","value":"1.24","vol":"3.32"},{"date":"2024-09-30","value":"1.22","vol":"3.66"},{"date":"2024-06-30","value":"1.24","vol":"3.59"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 流动比率 |
1.27 | 1.21 | 1.24 | 1.22 | 1.24 |
| 行业 | 3.66 | 3.59 | 3.32 | 3.66 | 3.59 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"0.63","vol":"2.88"},{"date":"2025-03-31","value":"0.58","vol":"2.81"},{"date":"2024-12-31","value":"0.69","vol":"2.63"},{"date":"2024-09-30","value":"0.66","vol":"2.92"},{"date":"2024-06-30","value":"0.73","vol":"2.88"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 速动比率 |
0.63 | 0.58 | 0.69 | 0.66 | 0.73 |
| 行业 | 2.88 | 2.81 | 2.63 | 2.92 | 2.88 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 3/218 ， 32/218。
[{"date":"2025-06-30","value":"49.71","vol":"33.92"},{"date":"2025-03-31","value":"50.05","vol":"34.04"},{"date":"2024-12-31","value":"50.73","vol":"34.34"},{"date":"2024-09-30","value":"50.93","vol":"33.02"},{"date":"2024-06-30","value":"51.35","vol":"33.19"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
49.71 | 50.05 | 50.73 | 50.93 | 51.35 |
| 行业(%) | 33.92 | 34.04 | 34.34 | 33.02 | 33.19 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"1.03","vol":"0.89"},{"date":"2025-03-31","value":"1.05","vol":"1.46"},{"date":"2024-12-31","value":"1.08","vol":"0.84"},{"date":"2024-09-30","value":"1.08","vol":"0.73"},{"date":"2024-06-30","value":"1.10","vol":"0.71"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
1.03 | 1.05 | 1.08 | 1.08 | 1.10 |
| 行业(%) | 0.89 | 1.46 | 0.84 | 0.73 | 0.71 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
机构预测该股2025年每股收益与前一年相同，长期投资价值一般。
[{"date":"2021","yellowRectValue":"1.43","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"3.39","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"0.12","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"0.67","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"1.45","blueLineValue":"0.66","type":"YC"}]